These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 37212551

  • 1. Loss of hepatic PPARα in mice causes hypertension and cardiovascular disease.
    Badmus OO, Kipp ZA, Bates EA, da Silva AA, Taylor LC, Martinez GJ, Lee WH, Creeden JF, Hinds TD, Stec DE.
    Am J Physiol Regul Integr Comp Physiol; 2023 Jul 01; 325(1):R81-R95. PubMed ID: 37212551
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hepatic MIR20B promotes nonalcoholic fatty liver disease by suppressing PPARA.
    Lee YH, Jang HJ, Kim S, Choi SS, Khim KW, Eom HJ, Hyun J, Shin KJ, Chae YC, Kim H, Park J, Park NH, Woo CY, Hong CH, Koh EH, Nam D, Choi JH.
    Elife; 2021 Dec 29; 10():. PubMed ID: 34964438
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.
    Li X, Wang Z, Klaunig JE.
    Toxicology; 2019 Mar 15; 416():1-14. PubMed ID: 30711707
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Conophylline inhibits high fat diet-induced non-alcoholic fatty liver disease in mice.
    Ohashi T, Nakade Y, Ibusuki M, Kitano R, Yamauchi T, Kimoto S, Inoue T, Kobayashi Y, Sumida Y, Ito K, Nakao H, Umezawa K, Yoneda M.
    PLoS One; 2019 Mar 15; 14(1):e0210068. PubMed ID: 30689650
    [Abstract] [Full Text] [Related]

  • 13. Alternate-day fasting alleviates high fat diet induced non-alcoholic fatty liver disease through controlling PPARα/Fgf21 signaling.
    Liu X, Zhang Y, Ma C, Lin J, Du J.
    Mol Biol Rep; 2022 Apr 15; 49(4):3113-3122. PubMed ID: 35107741
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
    Yan F, Wang Q, Lu M, Chen W, Song Y, Jing F, Guan Y, Wang L, Lin Y, Bo T, Zhang J, Wang T, Xin W, Yu C, Guan Q, Zhou X, Gao L, Xu C, Zhao J.
    J Hepatol; 2014 Dec 15; 61(6):1358-64. PubMed ID: 25016220
    [Abstract] [Full Text] [Related]

  • 18. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
    Bai J, Xia M, Xue Y, Ma F, Cui A, Sun Y, Han Y, Xu X, Zhang F, Hu Z, Liu Z, Liu Y, Cai G, Su W, Sun X, Wu H, Yan H, Chang X, Hu X, Bian H, Xia P, Gao J, Li Y, Gao X.
    EBioMedicine; 2020 Jul 15; 57():102849. PubMed ID: 32580141
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.